Assignee
WISTAR INST
US179 patents
Top patents by PatentIndex Score
US6019978AFeb 1, 2000
Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
WISTAR INST125 citations99
US5593972AJan 14, 1997
Genetic immunization
WISTAR INST807 citations99
US4172124AOct 23, 1979
Method of producing tumor antibodies
WISTAR INST273 citations99
US5571515ANov 5, 1996
Compositions and methods for use of IL-12 as an adjuvant
WISTAR INST108 citations98
US5015568AMay 14, 1991
Diagnostic methods for detecting lymphomas in humans
WISTAR INST141 citations97
US5714316AFeb 3, 1998
Chimeric envelope proteins for viral targeting
WISTAR INST99 citations96
US5698202ADec 16, 1997
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
WISTAR INST92 citations96
US5591439AJan 7, 1997
Recombinant cytomegalovirus vaccine
WISTAR INST145 citations96
US5202429AApr 13, 1993
DNA molecules having human BCL-2 gene sequences
WISTAR INST124 citations96
US4608337AAug 26, 1986
Human hybridomas and the production of human monoclonal antibodies by human hybridomas
WISTAR INST55 citations96
US4196265AApr 1, 1980
Method of producing antibodies
WISTAR INST841 citations96
US5595869AJan 21, 1997
Diagnostic methods for detecting lymphomas in humans
WISTAR INST56 citations95
US5470571ANov 28, 1995
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
WISTAR INST86 citations95
US5459251AOct 17, 1995
DNA molecules having human bcl-2 gene sequences
WISTAR INST98 citations95
US4471057ASep 11, 1984
Detection of colorectal carcinoma
WISTAR INST103 citations95
US9402888B2Aug 2, 2016
Methods and compositions for treating cancer
WISTAR INST29 citations94
US5837249ANov 17, 1998
Method for generating an immunogenic T cell response protective against a virus
WISTAR INST69 citations94
US5523393AJun 4, 1996
BCL-2 proteins
WISTAR INST63 citations94
US5506344AApr 9, 1996
Antibodies specific for BCL-2 gene product
WISTAR INST54 citations94
US5272082ADec 21, 1993
Cytotoxic T-ALL cell lines and uses therefor
WISTAR INST57 citations94
US4849509AJul 18, 1989
Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies
WISTAR INST90 citations94
US4693975ASep 15, 1987
Human hybridroma fusion partner for production of human monoclonal antibodies
WISTAR INST64 citations94
US5633142AMay 27, 1997
WT1 monoclonal antibodies and methods of use therefor
WISTAR INST43 citations93
US5582996ADec 10, 1996
Bifunctional antibodies and method of preparing same
WISTAR INST310 citations93
US5552143ASep 3, 1996
Recombinant cytomegalovirus vaccine
WISTAR INST70 citations93
US4701409AOct 20, 1987
Detection of B-cell neoplasms
WISTAR INST46 citations93
US4349528ASep 14, 1982
Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
WISTAR INST50 citations93
US6287571B1Sep 11, 2001
Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
WISTAR INST23 citations92
US6210663B1Apr 3, 2001
Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
WISTAR INST38 citations92
US6168923B1Jan 2, 2001
Compositions and methods for use of IL-12 as an adjuvant
WISTAR INST30 citations92
US5976539ANov 2, 1999
Compositions and methods for use of IL-12 as an adjuvant
WISTAR INST19 citations92
US4971792ANov 20, 1990
Monoclonal antibodies against glycolipid antigens
WISTAR INST68 citations92
US6638408B1Oct 28, 2003
Method and device for separation of charged molecules by solution isoelectric focusing
WISTAR INST52 citations91
US4636385AJan 13, 1987
Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
WISTAR INST44 citations91
US9226936B2Jan 5, 2016
Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
WISTAR INST13 citations90
US6852706B1Feb 8, 2005
Methods and compositions for healing heart wounds
WISTAR INST36 citations90
US6375944B1Apr 23, 2002
Methods and compositions for enhancing the immunostimulatory effect of interleukin-12
WISTAR INST55 citations90
US5626851AMay 6, 1997
Rotavirus reassortant vaccine
WISTAR INST26 citations90
US5246921ASep 21, 1993
Method for treating leukemias
WISTAR INST130 citations90
US5130127AJul 14, 1992
Human tumor therapy using beta (1-3) glucanlentinan and anti-tumor antibodies
WISTAR INST41 citations90
US4108983AAug 22, 1978
Viral oncolysate vaccine for stimulating the immune mechanism of mammals to species-specific tumors
WISTAR INST62 citations90
US6555579B2Apr 29, 2003
Methods for reducing atherosclerotic plaques
WISTAR INST22 citations89
US5622835AApr 22, 1997
WT1 monoclonal antibodies
WISTAR INST41 citations89
US5573925ANov 12, 1996
P53 proteins with altered tetramerization domains
WISTAR INST30 citations89
US5296348AMar 22, 1994
Methods for screening monoclonal antibodies for therapeutic use
WISTAR INST31 citations89
US4664097AMay 12, 1987
Nuclear transplantation in the mammalian embryo by microsurgery and cell fusion
WISTAR INST38 citations89
US4334016AJun 8, 1982
Human osteogenic sarcoma cell line and use thereof for immunofluorescent antibody test
WISTAR INST38 citations89
US5789158AAug 4, 1998
Developmental embryonic mouse cDNA libraries
WISTAR INST59 citations88
US5688690ANov 18, 1997
Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
WISTAR INST29 citations88
US5182192AJan 26, 1993
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
WISTAR INST32 citations88
Showing the top 50 of 179 patents by PatentIndex Score.